Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin

Toxicology and Applied Pharmacology

Volumn 241, Issue 2, 2009, Pages 143-153

  Charlson, Aaron T ^a   Zeliadt, Nicholette A ^a   Wattenberg, Elizabeth V ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Extracellular signal regulated kinase 5; Mitogen activated protein kinase; Na+,K+ ATPase; Palytoxin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYCLOHEXIMIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; OKADAIC ACID; OUABAIN; PALYTOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C FOS; PROTEIN TYROSINE PHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; VANADATE SODIUM;

ANIMAL CELL; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

ACRYLAMIDES; ADENOSINE TRIPHOSPHATASES; ANIMALS; CARCINOGENS; CYCLOHEXIMIDE; ENZYME INHIBITORS; HELA CELLS; HUMANS; KERATINOCYTES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 7; OKADAIC ACID; OUABAIN; PROTEIN SYNTHESIS INHIBITORS; VANADATES;

STROPHANTHUS GRATUS;

EID: 70350214528     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.08.021     Document Type: Article

References (59)

1. Abe J., Kusuhara M., Ulevitch R.J., Berk B.C., and Lee J.D. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J. Biol. Chem. 271 (1996) 16586-16590
2. Alcala A.C., Alcala L.C., Garth J.S., Yasumura D., and Yasumoto T. Human fatality due to ingestion of the crab Demania reynaudii that contained a palytoxin-like toxin. Toxicon 26 (1988) 105-107
3. Balmain A., and Pragnell I.B. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 303 (1983) 72-74
4. Bialojan C., and Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem. J. 256 (1988) 283-290
5. Cavigelli M., Dolfi F., Claret F.X., and Karin M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14 (1995) 5957-5964
6. Chao T.H., Hayashi M., Tapping R.I., Kato Y., and Lee J.D. MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. J. Biol. Chem. 274 (1999) 36035-36038
7. Dhillon A.S., Hagan S., Rath O., and Kolch W. MAP kinase signalling pathways in cancer. Oncogene 26 (2007) 3279-3290
8. Emanuel J.R., Schulz J., Zhou X.M., Kent R.B., Housman D., Cantley L., and Levenson R. Expression of an ouabain-resistant Na,K-ATPase in CV-1 cells after transfection with a cDNA encoding the rat Na,K-ATPase alpha 1 subunit. J. Biol. Chem. 263 (1988) 7726-7733
9. Esparis-Ogando A., Diaz-Rodriguez E., Montero J.C., Yuste L., Crespo P., and Pandiella A. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol. Cell. Biol. 22 (2002) 270-285
10. Fujiki H., Suganuma M., Nakayasu M., Hakii H., Horiuchi T., Takayama S., and Sugimura T. Palytoxin is a non-12-O-tetradecanoylphorbol-13-acetate type tumor promoter in two-stage mouse skin carcinogenesis. Carcinogenesis 7 (1986) 707-710
11. Gille H., Strahl T., and Shaw P.E. Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr. Biol. 5 (1995) 1191-1200
12. Habermann E. Palytoxin acts through Na+,K+-ATPase. Toxicon 27 (1989) 1171-1187
13. Hayashi M., and Lee J.D. Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice. J. Mol. Med. 82 (2004) 800-808
14. Hayashi M., Fearns C., Eliceiri B., Yang Y., and Lee J.D. Big mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis. Cancer Res. 65 (2005) 7699-7706
15. Hoffmann K., Hermanns-Clausen M., Buhl C., Buchler M.W., Schemmer P., Mebs D., and Kauferstein S. A case of palytoxin poisoning due to contact with zoanthid corals through a skin injury. Toxicon 51 (2008) 1535-1537
16. Ishida Y., Takagi K., Takahashi M., Satake N., and Shibata S. Palytoxin isolated from marine coelenterates. The inhibitory action on (Na,K)-ATPase. J. Biol. Chem. 258 (1983) 7900-7902
17. Janknecht R., Ernst W.H., and Nordheim A. SAP1a is a nuclear target of signaling cascades involving ERKs. Oncogene 10 (1995) 1209-1216
18. Kamakura S., Moriguchi T., and Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J. Biol. Chem. 274 (1999) 26563-26571
19. Kato Y., Kravchenko V.V., Tapping R.I., Han J., Ulevitch R.J., and Lee J.D. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16 (1997) 7054-7066
20. Kato Y., Tapping R.I., Huang S., Watson M.H., Ulevitch R.J., and Lee J.D. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 395 (1998) 713-716
21. Kodama A.M., Hokama Y., Yasumoto T., Fukui M., Manea S.J., and Sutherland N. Clinical and laboratory findings implicating palytoxin as cause of ciguatera poisoning due to Decapterus macrosoma (mackerel). Toxicon 27 (1989) 1051-1053
22. Kuroki D.W., Bignami G.S., and Wattenberg E.V. Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin. Cancer Res 56 (1996) 637-644
23. Kuroki D.W., Minden A., Sanchez I., and Wattenberg E.V. Regulation of a c-Jun amino-terminal kinase/stress-activated protein kinase cascade by a sodium-dependent signal transduction pathway. J. Biol. Chem. 272 (1997) 23905-23911
24. Lazzaro M., Tashjian Jr. A.H., Fujiki H., and Levine L. Palytoxin: an extraordinarily potent stimulator of prostaglandin production and bone resorption in cultured mouse calvariae. Endocrinology 120 (1987) 1338-1345
25. Lee J.D., Ulevitch R.J., and Han J. Primary structure of BMK1: a new mammalian map kinase. Biochem. Biophys. Res. Commun. 213 (1995) 715-724
26. Levine L., Xiao D.M., and Fujiki H. Combinations of palytoxin or 12-O-tetradecanoylphorbol-13-acetate and recombinant human insulin growth factor-I or insulin synergistically stimulate prostaglandin production in cultured rat liver cells and squirrel monkey aorta smooth muscle cells. Prostaglandins 31 (1986) 669-681
27. Li S., and Wattenberg E.V. Differential activation of mitogen-activated protein kinases by palytoxin and ouabain, two ligands for the Na+,K+-ATPase. Toxicol. Appl. Pharmacol. 151 (1998) 377-384
28. Li S., and Wattenberg E.V. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin. Toxicol. Appl. Pharmacol. 160 (1999) 109-119
29. McCracken S.R., Ramsay A., Heer R., Mathers M.E., Jenkins B.L., Edwards J., Robson C.N., Marquez R., Cohen P., and Leung H.Y. Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer. Oncogene 27 (2008) 2978-2988
30. Mebs D. Occurrence and sequestration of toxins in food chains. Toxicon 36 (1998) 1519-1522
31. Millward T.A., Zolnierowicz S., and Hemmings B.A. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24 (1999) 186-191
32. Miura D., Kobayashi M., Kakiuchi S., Kasahara Y., and Kondo S. Enhancement of transformed foci and induction of prostaglandins in Balb/c 3T3 cells by palytoxin: in vitro model reproduces carcinogenic responses in animal models regarding the inhibitory effect of indomethacin and reversal of indomethacin's effect by exogenous prostaglandins. Toxicol. Sci. 89 (2006) 154-163
33. Mody N., Leitch J., Armstrong C., Dixon J., and Cohen P. Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett. 502 (2001) 21-24
34. Mody N., Campbell D.G., Morrice N., Peggie M., and Cohen P. An analysis of the phosphorylation and activation of extracellular-signal-regulated protein kinase 5 (ERK5) by mitogen-activated protein kinase kinase 5 (MKK5) in vitro. Biochem. J. 372 (2003) 567-575
35. Montero J.C., Ocana A., Abad M., Ortiz-Ruiz M.J., Pandiella A., and Esparis-Ogando A. Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target. PLoS ONE e5565 (2009) 4
36. Moore R.E. Structure of palytoxin. Fortschr. Chem. Org. Naturst. 48 (1985) 81-202
37. Moore R.E., and Scheuer P.J. Palytoxin: a new marine toxin from a coelenterate. Science 172 (1971) 495-498
38. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308 (1984) 693-698
39. Onuma Y., Satake M., Ukena T., Roux J., Chanteau S., Rasolofonirina N., Ratsimaloto M., Naoki H., and Yasumoto T. Identification of putative palytoxin as the cause of clupeotoxism. Toxicon 37 (1999) 55-65
40. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., and Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16 (1996) 1247-1255
41. Sasaki T., Kojima H., Kishimoto R., Ikeda A., Kunimoto H., and Nakajima K. Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol. Cell 24 (2006) 63-75
42. Sawhney R.S., Liu W., and Brattain M.G. A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling. J. Cell. Physiol. 219 (2009) 152-161
43. Scapoli L., Ramos-Nino M.E., Martinelli M., and Mossman B.T. Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos. Oncogene 23 (2004) 805-813
44. Schmittgen T.D., and Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3 (2008) 1101-1108
45. Strahl T., Gille H., and Shaw P.E. Selective response of ternary complex factor Sap1a to different mitogen-activated protein kinase subgroups. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11563-11568
46. Strickland J.E., Greenhalgh D.A., Koceva-Chyla A., Hennings H., Restrepo C., Balaschak M., and Yuspa S.H. Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res. 48 (1988) 165-169
47. Sun W., Kesavan K., Schaefer B.C., Garrington T.P., Ware M., Johnson N.L., Gelfand E.W., and Johnson G.L. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. J. Biol. Chem. 276 (2001) 5093-5100
48. Terasawa K., Okazaki K., and Nishida E. Regulation of c-Fos and Fra-1 by the MEK5-ERK5 pathway. Genes Cells 8 (2003) 263-273
49. Turjanski A.G., Vaque J.P., and Gutkind J.S. MAP kinases and the control of nuclear events. Oncogene 26 (2007) 3240-3253
50. Wang X., and Tournier C. Regulation of cellular functions by the ERK5 signalling pathway. Cell. Signal. 18 (2006) 753-760
51. Warmka J.K., Mauro L.J., and Wattenberg E.V. Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras. J. Biol. Chem. 279 (2004) 33085-33092
52. Warmka J.K., Winston S.E., Zeliadt N.A., and Wattenberg E.V. Extracellular signal-regulated kinase transmits palytoxin-stimulated signals leading to altered gene expression in mouse keratinocytes. Toxicol. Appl. Pharmacol. 185 (2002) 8-17
53. Wattenberg E.V., Fujiki H., and Rosner M.R. Heterologous regulation of the epidermal growth factor receptor by palytoxin, a non-12-O-tetradecanoylphorbol-13-acetate-type tumor promoter. Cancer Res. 47 (1987) 4618-4622
54. Whitmarsh A.J., Shore P., Sharrocks A.D., and Davis R.J. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269 (1995) 403-407
55. Woo C.H., Shishido T., McClain C., Lim J.H., Li J.D., Yang J., Yan C., and Abe J. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells. Circ. Res. 102 (2008) 538-545
56. Yordy J.S., and Muise-Helmericks R.C. Signal transduction and the Ets family of transcription factors. Oncogene 19 (2000) 6503-6513
57. Yuspa S.H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J. Dermatol. Sci. 17 (1998) 1-7
58. Zeliadt N.A., Warmka J.K., Winston S.E., Kahler R., Westendorf J.J., Mauro L.J., and Wattenberg E.V. Tumor promoter-induced MMP-13 gene expression in a model of initiated epidermis. Biochem. Biophys. Res. Commun. 317 (2004) 570-577
59. Zhou G., Bao Z.Q., and Dixon J.E. Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 270 (1995) 12665-12669